688046.SSShanghai
GemPharmatech Co., Ltd.
¥17.79
ListedApr 25, 2022
SectorHealthcare
IndustryBiotechnology
CountryChina
Employees1590
State-| CityNanjing| AddressNo. 12 Xuefu Road| Phone86 25 5824 3997
GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
48.5
?
Div. Rate
¥0.14
?
Div. Yield
0.72%
?
Payout Ratio
35.00%
?
Max Consec. Div. Years
3 years
?
Longest Consec. Div.
3 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.61
?
Div. Growth Rate
50.00%
?
Score
72

Dividend History

Historical dividend payments by ex-dividend date.

Nov 20, 2025
¥ 0.0300
Jul 11, 2025
¥ 0.1100
Nov 4, 2024
¥ 0.0300
Aug 7, 2024
¥ 0.1600
Jul 7, 2023
¥ 0.0410

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!